Binding of Hydrochlorothiazide to Erythrocytes

概要

論文の詳細を見る
Hydrochlorothiazide (HCT) was administered orally to healthy volunteers and intravenously to rabbits. HCT concentrations in plasma (C_p) and erythrocytes (C_e) were determined by a high-performance liquid chromatographic method. C_e was about 9-fold that of C_p 24 h after the administration to volunteers, and 8-fold 6 h after the administration to rabbits. From the results of the in vitro binding study which was done with rabbits erythrocytes, at least the presence of three kinds of binding site for HCT was expected. The first binding site was characterized by extremely high affinity and very low capacity, and was unaffected by acetazolamide, known as a carbonic anhydrase inhibitor. The second one was characterized by medium affinity and medium capacity, and disappeared under the presence of acetazolamide and may be due to the carbonic anhydrase of erythrocytes. The third one was characterized by low affinity, but its binding capacity was extremely high and apparently unsaturable in the HCT concentration range studies (0.5-100μg/ml=1.68-336μM). The binding of HCT to erythrocytes seems to be dominated by the second binding site in the therapeutic range (under 1 μg/ml of plasma).
公益社団法人日本薬学会の論文